Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06746428 · ClinicalTrials.gov registry record · NA
Activity Coaching During Pelvic Radiation Therapy
A NA study of Gynecologic Cancer and Radiation Therapy, sponsored by Inova Health Care Services.
- Recruiting
- Registry status
- NA
- Development phase
- 16
- Enrollment target
- 4
- Study locations
NCT06746428: Recruiting NA study of Gynecologic Cancer and Radiation Therapy, sponsored by Inova Health Care Services.
NCT06746428 is a NA study of Gynecologic Cancer and Radiation Therapy that is actively recruiting participants, run by Inova Health Care Services. The registered enrollment target is 16 participants, below the 764-participant average among 55 other Gynecologic Cancer trials with a reported enrollment target (98% lower). The trial reports 4 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06746428, a NA study of Gynecologic Cancer and Radiation Therapy, is actively recruiting participants, sponsored by Inova Health Care Services.
- RECRUITING
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
- 4
- Study locations
Study Summary
Research has shown that for women who are undergoing pelvic radiation therapy, fatigue is a common side effect. Fatigue that occurs during radiation therapy can make it harder to perform daily living activities. While there are studies that recommend exercise as a treatment for fatigue in cancer patients and survivors, there are currently no studies that focus on the role of exercise for women undergoing pelvic radiation therapy. The purpose of this study is to see if incorporating an activity coaching program is helpful in improving treatment-related fatigue for women undergoing pelvic radiation therapy for endometrial cancer.
Primary Outcome
Participant adherence to coaching sessions will be defined as complete adherence when engaging in 10 of the 10 planned exercise coaching sessions and high adherence as engaging in at least 7 of the planned 10 exercise coach check-ins. Participant adherence will be considered feasible if 70% of participants adhere to the coaching sessions.
Conditions Studied
Interventions
- BEHAVIORAL Exercise Coaching
Study Locations (4)
Virginia
- Inova Schar Cancer Institute - Alexandria - Alexandria
- Inova Schar Cancer Institute - Fairfax
- Inova Schar Cancer Institute - Fair Oaks - Fairfax
- Inova Schar Cancer Institute - Loudoun - Leesburg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2025-01-27 |
| Est. Completion | 2026-07-01 |
| Phase | NA |
What NCT06746428 shows while recruiting
NCT06746428 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 764-participant average among 55 other Gynecologic Cancer trials with a reported enrollment target (98% lower).
The record links to 3 conditions, with Gynecologic Cancer appearing as the primary indexed condition, and to 1 intervention - of which Exercise Coaching is the first listed.
NCT06746428 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT06746428 about?
NCT06746428 is a clinical study titled "Activity Coaching During Pelvic Radiation Therapy". Research has shown that for women who are undergoing pelvic radiation therapy, fatigue is a common side effect. Fatigue that occurs during radiation therapy can make it harder to perform daily living activities. While there are studies that recommend exercise as a treatment for fatigue in cancer pat...
What is the current status of trial NCT06746428?
This trial is currently recruiting. It is a NA study. The enrollment target is 16 participants. The study started on 2025-01-27. Estimated completion is 2026-07-01.
What conditions does trial NCT06746428 study?
This clinical trial studies the following conditions: Gynecologic Cancer, Radiation Therapy, Exercise Therapy.
What interventions are being tested in trial NCT06746428?
The interventions under investigation include: Exercise Coaching (BEHAVIORAL).
Who is sponsoring clinical trial NCT06746428?
This trial is sponsored by Inova Health Care Services, which has 75 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06746428 being conducted?
This trial has 4 study locations across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gynecologic Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06746428's enrollment target sits among peer trials
16 52nd of 55 higher than 4 of 55 other Gynecologic Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gynecologic Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors
RECRUITING · NA
-
Chatbot to Maximize Hereditary Cancer Genetic Risk Assessment
RECRUITING · NA
-
BOLSTER: Learning New Skills to Thrive
RECRUITING · NA
-
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
RECRUITING · NA
-
Transcranial Magnetic Stimulation for Chemotherapy-Induced Peripheral Neuropathy in Breast and Gynecologic Cancer Survivors
RECRUITING · NA
-
Improve Cancer-related Cognitive Impairment
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI